Katia M. C. Verhamme

Katia M. C. Verhamme

Auto-generated profile, based on publicly available information

Katia M. C. Verhamme

Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Drug Safety
Verified
Journal Article
Closed access
PDF file
KVKatia M. C. Verhamme
Katia M. C. Verhamme
MSMiriam C. J. M. Sturkenboom
Miriam C. J. M. Sturkenboom
BSBruno H. Ch Stricker
Bruno H. Ch Stricker
RBRuud Bosch
Ruud Bosch

1 November 2003 in European Urology
Verified
Journal Article
Closed access
KVK.M.C. Verhamme
K.M.C. Verhamme
JDJ.P. Dieleman
J.P. Dieleman
GBG.S. Bleumink
G.S. Bleumink
JBJ.L.H.R. Bosch
J.L.H.R. Bosch
BSB.H.Ch. Stricker
B.H.Ch. Stricker
MSM.C.J.M. Sturkenboom
M.C.J.M. Sturkenboom

1 April 2020 in Respiratory Medicine
Verified
Journal Article
Closed access
MEMarjolein Engelkes
Marjolein Engelkes
MRMaria Aj de Ridder
Maria Aj de Ridder
ESElisabeth Svensson
Elisabeth Svensson
KBKlara Berencsi
Klara Berencsi
DPDaniel Prieto-Alhambra
Daniel Prieto-Alhambra
KVKatia MC Verhamme
Katia MC Verhamme

19 April 2020 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
JAJohnmary T. Arinze
Johnmary T. Arinze
EREmmely W. de Roos
Emmely W. de Roos
LKLeila Karimi
Leila Karimi
KVKatia M.C. Verhamme
Katia M.C. Verhamme
BSBruno H. Stricker
Bruno H. Stricker
GBGuy G. Brusselle
Guy G. Brusselle
Chronic cough is a common complaint in the general population but there are no precise data on the incidence of, and prospectively examined risk factors for chronic cough in a population-based setting. Therefore, we investigated the period prevalence, incidence and risk factors for chronic cough in adult subjects.In a prospective population-based cohort study among subjects aged ≥45 years, data on chronic cough were collected on two separate occasions using a standardised questionnaire. Chronic cough was defined as daily coughing for at least 3 months duration during the preceding 2 years. Potential risk factors were gathered by interview, physical examination and several investigations.Of the 9824 participants in this study, 1073 (10.9%) subjects had chronic cough at baseline. The prevalence of chronic cough increased with age and peaked in the eighth decade. In subjects aged <70 years, chronic cough was more common in women. During an average follow-up of 6 years, 439 incident cases of chronic cough occurred with an overall incidence rate of 11.6 per 1000 person-years (95% CI 10.6–12.8). In current smokers, the incidence of chronic cough was higher in men. In the multivariable analysis, current smoking, gastro-oesophageal reflux disease (GORD), asthma and COPD were identified as risk factors for chronic cough.Chronic cough is common among adults and highly prevalent in the older population. Current smoking, GORD, asthma and COPD are independent risk factors for chronic cough. Individuals at risk of developing chronic cough may benefit from smoking cessation and control of the underlying disease.

23 December 2021 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
EBElizabeth Benz
Elizabeth Benz
SWSara Wijnant
Sara Wijnant
KTKaterina Trajanoska
Katerina Trajanoska
JAJohnmary T. Arinze
Johnmary T. Arinze
EREmmely W. de Roos
Emmely W. de Roos
GBGuy G. Brusselle
Guy G. Brusselle
Background: Increasing evidence suggests that sarcopenia and a higher systemic immune-inflammation index (SII) are linked with morbidity in patients with COPD. However, whether these two conditions contribute to all-cause mortality in middle-aged and older patients with COPD or asthma is unclear. Therefore, we investigated the association between sarcopenia, SII, COPD or asthma and all-cause mortality in a large-scale population-based setting.Methods: Between 2009 and 2014, 4482 participants (aged >55 years; 57.3% female) from the population-based Rotterdam Study were included. COPD and asthma patients were diagnosed clinically and based on spirometry. Six study groups were defined according to the presence or absence of COPD or asthma and sarcopenia. Cox regression models were used to assess all-cause mortality in the study groups, adjusted for sex, age, body mass index, SII, smoking, oral corticosteroid use and comorbidities. In addition, all participants were categorised into sex-specific quartiles of SII, and mortality in these groups was compared.Results: Over a median follow-up of 6.1 years (interquartile range 5.0–7.2 years), 466 (10.4%) persons died. Independent of the presence of sarcopenia, participants with COPD had a higher risk of all-cause mortality (hazard ratio (HR) 2.13, 95% CI 1.46–3.12 and HR 1.70, 95% CI 1.32–2.18 for those with and without sarcopenia, respectively). Compared to lower SII levels, higher SII levels increased mortality risk even in people without sarcopenia, COPD or asthma.Conclusion: Middle-aged and older people with COPD, higher SII levels or sarcopenia had an independently increased mortality risk. Our study suggests prognostic usefulness of routinely evaluating sarcopenia and SII in older people with COPD or asthma.

1 April 2005 in European Urology
Verified
Journal Article
Closed access
KVK.M.C. Verhamme
K.M.C. Verhamme
JDJ.P. Dieleman
J.P. Dieleman
MWM.A.M. van Wijk
M.A.M. van Wijk
JBJ.L.H.R. Bosch
J.L.H.R. Bosch
BSB.H.CH. Stricker
B.H.CH. Stricker
MSM.C.J.M. Sturkenboom
M.C.J.M. Sturkenboom